Clear Perspective Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$604K Sell
9,680
-1,846
-16% -$108K 0.18% 85
2021
Q3
$682K Sell
11,526
-123
-1% -$8.1K 0.23% 72
2021
Q2
$778K Buy
11,649
+690
+6% +$45K 0.27% 66
2021
Q1
$692K Buy
10,959
+781
+8% +$48.6K 0.27% 71
2020
Q4
$631K Buy
10,178
+982
+11% +$60.4K 0.26% 72
2020
Q3
$1.63K Buy
9,196
+1,111
+14% +$66.9K 0.77% 27
2020
Q2
$475K Buy
8,085
+2,622
+48% +$157K 0.26% 72
2020
Q1
$305K Sell
5,463
-500
-8% -$30.6K 0.2% 83
2019
Q4
$383K Sell
5,963
-512
-8% -$29.3K 0.24% 92
2019
Q3
$328K Sell
6,475
-100
-2% -$4.7K 0.15% 104
2019
Q2
$298K Sell
6,575
-500
-7% -$23.3K 0.19% 108
2019
Q1
$326K Buy
7,075
+200
+3% +$9.96K 0.23% 102
2018
Q4
$357K Buy
6,875
+100
+1% +$5.37K 0.3% 91
2018
Q3
$421K Sell
6,775
-100
-1% -$5.93K 0.31% 95
2018
Q2
$380K Buy
6,875
+50
+0.7% +$2.7K 0.27% 98
2018
Q1
$432K Sell
6,825
-50
-0.7% -$3.22K 0.32% 83
2017
Q4
$421K Sell
6,875
-875
-11% -$54.7K 0.32% 82
2017
Q3
$494K Sell
7,750
-300
-4% -$17.5K 0.4% 69
2017
Q2
$449K Sell
8,050
-50
-0.6% -$2.72K 0.38% 72
2017
Q1
$440K Sell
8,100
-2,500
-24% -$137K 0.29% 74
2016
Q4
$619K Buy
+10,600
New +$580K 0.41% 58

Other funds holding BMY

Clear Perspective Advisors's BMY Position: Q4 2021 in Review

Clear Perspective Advisors reduced its Bristol-Myers Squibb (BMY) stake by 16% in Q4 2021, selling an estimated $108K and leaving 9,680 shares worth $604K. The position accounts for 0.18% of the portfolio, ranked #85.

Clear Perspective Advisors first reported a position in BMY in Q4 2016 and has held it in 21 quarters since. The position peaked at $778K in Q2 2021. 2,445 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

  • Clear Perspective Advisors held 9,680 shares of Bristol-Myers Squibb worth $604K as of Q4 2021.
  • Clear Perspective Advisors sold 1,846 Bristol-Myers Squibb shares in Q4 2021, an estimated $108K.
  • Bristol-Myers Squibb made up 0.18% of Clear Perspective Advisors's portfolio in Q4 2021, its #85 holding.
  • Clear Perspective Advisors first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 21 quarters since.
  • Clear Perspective Advisors's Bristol-Myers Squibb position peaked at $778K in Q2 2021.
  • 2,445 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Clear Perspective Advisors's 13F filing for Q4 2021, filed 17 Feb 2022.